Women's Health Initiative estrogen plus progestin clinical trial: a study that does not allow establishing relevant clinical risks. [electronic resource]
Producer: 20160912Description: 1317-22 p. digitalISSN:- 1530-0374
- Breast Neoplasms -- mortality
- Colorectal Neoplasms -- mortality
- Coronary Disease -- mortality
- Estrogen Replacement Therapy -- adverse effects
- Estrogens, Conjugated (USP) -- administration & dosage
- Female
- Hip Fractures -- mortality
- Humans
- Medroxyprogesterone Acetate -- administration & dosage
- Monte Carlo Method
- Placebos
- Proportional Hazards Models
- Pulmonary Embolism -- mortality
- Randomized Controlled Trials as Topic
- Risk Factors
- Stroke -- mortality
- Survival Rate
- Women's Health
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.